Home › Leukemia › North Carolina › Durham
Pag-aaral pangklinika para sa Leukemia sa Durham, NC
14 pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mi ang layo
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 2
- Durham VA Medical Center, Durham, NC, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Nagre-recruitObservasyonal na pag-aaral
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
A Study of Revumenib and Mezigdomide in People With Leukemia
Nagre-recruitPhase 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mi ang layo
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
- Duke University Medical Center, Durham
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
- Duke University, Durham
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Nagre-recruit
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi ang layo
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Duke Blood Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo
Pag-aaral para sa Leukemia sa ibang lungsod
- Houston, TX31 pag-aaral
- Boston, MA27 pag-aaral
- New York City, NY21 pag-aaral
- Chicago, IL19 pag-aaral
- Los Angeles, CA17 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Nashville, TN13 pag-aaral
- Columbus, OH13 pag-aaral
- Philadelphia, PA13 pag-aaral
- Atlanta, GA12 pag-aaral
- Milwaukee, WI12 pag-aaral
- Seattle, WA12 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso63 pag-aaral
- Kanser (lahat ng uri)61 pag-aaral
- Non-Small Cell Lung Cancer42 pag-aaral
- Multiple Myeloma36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Kanser sa Baga33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Colorectal Cancer30 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Chronic Lymphocytic Leukemia28 pag-aaral
- Pagkabigo ng Puso25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.